公开(公告)号：US20240327930A1

公开(公告)日：2024-10-03

申请号：US18681604

申请日：2022-08-05

申请人： IMMUNIS.AI, INC.

发明人： Amin I. Kassis ,  Geoffrey Erickson ,  Kirk J. Wojno ,  Leander Van Neste ,  Ricardo Henao ,  Harry Stylli

IPC分类号： C12Q1/6886 ,  G01N33/50 ,  G01N33/569 ,  G01N33/574

CPC分类号： C12Q1/6886 ,  G01N33/5047 ,  G01N33/56972 ,  G01N33/57434 ,  C12Q2600/118 ,  C12Q2600/158 ,  G01N2800/56

摘要： The present disclosure relates to compositions and methods for assessing prostate cancer (e.g., identification of the aggressiveness or indolence of prostate cancer) in a subject. The compositions and methods include obtaining subject specific information (e.g., age, digital rectal exam (DRE) data, prostate volume, prostate density, total prostate-specific antigen (PSA)) and obtaining a biological sample from a subject and determining a measurement for a panel of biomarkers in the biological sample. Compositions and methods of the disclosure find use in both clinical and research settings, for example, within the fields of biology, immunology, medicine, and oncology.